Journal article
Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction
Abstract
BACKGROUND: Cannabidiol (CBD) serves as a promising medicine, with few known adverse effects apart from the potential of drug interactions with the cytochrome P450 system. It has been hypothesized drug interactions may occur with chemotherapeutic agents, but no supporting evidence has been published to date.
CASE: A 58-year-old female with a history of bilateral breast carcinoma in remission, was treated with tamoxifen for breast cancer …
Authors
Parihar V; Rogers A; Blain AM; Zacharias SRK; Patterson LL; Siyam MA-M
Journal
Journal of Pharmacy Practice, Vol. 35, No. 2, pp. 322–326
Publisher
SAGE Publications
Publication Date
April 2022
DOI
10.1177/0897190020972208
ISSN
0897-1900